Mitologics S.A.S. is a biotechnology company specialized in detection of mitochondrial alterations. The company has developped technological platforms dedicated to compounds screening to identify compounds toxicity (DILI, cardio-toxicity) or efficacy (Oncology, Neuro-, Cardio-protection…). Among them, respiratory chain activity is measured in cultured cells or isolated mitochondria using Seahorse XFe-96 analyzer or soluble probes.

Since 2009, Mitologics has performed more than 200 R&D studies for pharmaceutical companies and biotech, as well as cosmetic and agro-chemistry companies especially in Europe, the United States and Japan.